Leaflet CERIS 20mg sugar-coated tablets
Product code: W51621001 Quantity: 30
Indicated for: overactive bladder; urinary incontinence
Route of administration: oral
Substance: trospium (urinary antimuscarinic)
ATC: G04BD09 (Genito urinary system and sex hormones | Urologicals | Drugs for urinary frequency and incontinence)
Use caution if you have glaucoma or increased eye pressure.
May cause dry mouth, constipation, urinary retention, or blurred vision.
Older people may have an increased risk of side effects.
Trospium is a medication used in the treatment of overactive bladder, a condition characterized by frequent urination, urinary urgency, and urinary incontinence. It is a muscarinic receptor antagonist that works by relaxing the bladder muscles and reducing involuntary contractions.
Trospium is administered orally in tablet form, with the dosage adjusted based on the severity of symptoms and the patient's response to treatment. It is important to take the medication on an empty stomach to maximize absorption.
Common side effects include dry mouth, constipation, nausea, and headache. In rare cases, allergic reactions or severe urinary retention may occur. Patients with pre-existing conditions such as narrow-angle glaucoma or renal impairment should use trospium with caution.
Trospium is an effective therapeutic option for managing overactive bladder symptoms, helping to improve patients' quality of life.
General data about CERIS 20mg
- Substance: trospium
- Date of latest medicines list: 01-07-2013
- Product code: W51621001
- Concentration: 20mg
- Pharmaceutical form: sugar-coated tablets
- Quantity: 30
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for trospium
Concentrations available for trospium
- 15mg
- 20mg
- 30mg